Stock comparison
Edwards Lifesciences
EW$49.38BHealthcare Market cap, Sector
Pro Medicus Limited
PME.AX$17.13BHealthcare Market cap, Sector
Overall winner
Pro Medicus Limited
EW 16 PME.AX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
EW1wins
6winsPME.AX
63C
B78
91A
A90
64C
A98
28F
A100
56D
B84
73B
A91
72B
A96
Side-by-side metrics
| Metric | EW | PME.AX |
|---|---|---|
| Market cap | Winner: $49.38B | $17.13B |
| P/E (TTM) | Winner: 43.2x | 147.6x |
| EV/EBIT | Winner: 27.6x | 106.8x |
| ROIC (TTM) | 12.06% | 42.56% Winner |
| Gross margin | 78.01% | 99.85% Winner |
| Net margin | 17.34% | 54.12% Winner |
| Revenue CAGR 5y | 3.77% | 31.61% Winner |
| EPS CAGR 5y | -6.52% | 37.34% Winner |
| Debt / Equity | 0.1x | 0.0x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
EW leads on
- EV/EBIT27.6xvs 106.8x+74%
- P/E (TTM)43.2xvs 147.6x+71%
- Market cap$49.38Bvs $17.13B+65%
PME.AX leads on
- EPS CAGR 5y37.34%vs -6.52%+117%
- Revenue CAGR 5y31.61%vs 3.77%+88%
- Debt / Equity0.0xvs 0.1x+87%
- ROIC (TTM)42.56%vs 12.06%+72%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.